نتائج البحث - "Holtschmidt, Johannes"

المؤلفون: Hirmas, Nader¹ (AUTHOR) nader.hirmas@gbg.de, Holtschmidt, Johannes¹ (AUTHOR) johannes.holtschmidt@gbg.de, Loibl, Sibylle^1,2 (AUTHOR) sibylle.loibl@gbg.de

المصدر: Cancers. Sep2024, Vol. 16 Issue 18, p3236. 31p.

مصطلحات موضوعية: *TRASTUZUMAB, *HORMONE receptor positive breast cancer, *BREAST tumors, *TREATMENT effectiveness, *IMMUNE checkpoint inhibitors, *COMBINED modality therapy, *ANTHRACYCLINES, *EVALUATION

Full Text Finder

5

Periodical

Präoperative Radiotherapie versus postoperative Radiotherapie nach neoadjuvanter Chemotherapie („NeoRad“) beim Hochrisikomammakarzinom: eine prospektive, randomisierte, internationale multizentrische Phase-III-Studie

المؤلفون: Matuschek, Christiane, Jazmati, Danny, Krug, David, Corradini, Stefanie, Fehm, Tanja, Ruckhäberle, Eugen, Kühn, Thorsten, Stickeler, Elmar, Nestle-Krämling, Carolin, Holtschmidt, Johannes, Nekljudova, Valentina, Loibl, Sibylle, Budach, Wilfried

المصدر: Die Onkologie; September 2024, Vol. 30 Issue: 9 p840-844, 5p

6

Academic Journal

GeparPiPPa: Eine randomisierte, offene Phase-II-Studie zum Vergleich einer neoadjuvanten Behandlung mit einer endokrinen Therapie in Kombination mit Trastuzumab und Pertuzumab ± PI3K-Inhibitor Inavolisib bei Patienten mit Hormonrezeptor-positivem, HER2-positivem primärem Mammakarzinom und einer PIK3CA-Mutation (German)

Alternate Title: GeparPiPPa: A randomized, open-label, phase II trial comparing neoadjuvant endocrine therapy in combination with trastuzumab and pertuzumab with/without the PI3K inhibitor inavolisib in patients with HR+/HER2+ primary breast cancer and a PIK3CA mutation. (English)

المؤلفون: Reinisch, Mattea, Seiler, Sabine, Holtschmidt, Johannes, Loibl, Sibylle

المصدر: Deutsche Krebsgesellschaft. Forum; Jun2024, Vol. 39 Issue 3, p227-231, 5p

7

Academic Journal

Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial

Relation: info:eu-repo/semantics/altIdentifier/issn/1533-4406; info:eu-repo/semantics/altIdentifier/pmid/39665649

الاتاحة: https://pub.uni-bielefeld.de/record/2999946

View record in BASE

8

Academic Journal

GeparPiPPa ; Eine randomisierte, offene Phase-II-Studie zum Vergleich einer neoadjuvanten Behandlung mit einer endokrinen Therapie in Kombination mit Trastuzumab und Pertuzumab ± PI3K-Inhibitor Inavolisib bei Patienten mit Hormonrezeptor-positivem, HER2-positivem primärem Mammakarzinom und einer PIK3CA-Mutation ; A randomized, open-label, phase II trial comparing neoadjuvant endocrine therapy in combination with trastuzumab and pertuzumab with/without the PI3K inhibitor inavolisib in patients with HR+/HER2+ primary breast cancer and a PIK3CA mutation

المؤلفون: Reinisch, Mattea, Seiler, Sabine, Holtschmidt, Johannes, Loibl, Sibylle

المصدر: Forum ; ISSN 0947-0255 2190-9784

الاتاحة: http://dx.doi.org/10.1007/s12312-024-01323-y
https://link.springer.com/content/pdf/10.1007/s12312-024-01323-y.pdf
https://link.springer.com/article/10.1007/s12312-024-01323-y/fulltext.html

View record in BASE

9

Periodical

GeparPiPPa

المؤلفون: Reinisch, Mattea, Seiler, Sabine, Holtschmidt, Johannes, Loibl, Sibylle

المصدر: Forum; June 2024, Vol. 39 Issue: 3 p227-231, 5p

10

Academic Journal

A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients

المصدر: Annals of Surgery ; volume 276, issue 5, page e553-e562 ; ISSN 0003-4932

الاتاحة: https://doi.org/10.1097/sla.0000000000004572
https://journals.lww.com/10.1097/SLA.0000000000004572

View record in BASE

11

Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/ERBB2-Positive Early Breast Cancer

المصدر: JAMA Oncology.

مصطلحات موضوعية: Cancer Research, Oncology, Medizin

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ce32265f6271f0c81c51a9d72da22a4
https://doi.org/10.1001/jamaoncol.2023.0646

View record in OpenAIRE

12

Academic Journal

Sacituzumab govitecan in HR+ and HER2- metastatic breast cancer: for all or for some?

المؤلفون: Loibl, Sibylle, Holtschmidt, Johannes

المصدر: The Lancet ; volume 402, issue 10411, page 1394-1395 ; ISSN 0140-6736

الاتاحة: http://dx.doi.org/10.1016/s0140-6736(23)01783-x
https://api.elsevier.com/content/article/PII:S014067362301783X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S014067362301783X?httpAccept=text/plain

View record in BASE

13

Academic Journal

Using a New Marker Clip System in Breast Cancer: Tumark Vision® Clip - Feasibility Testing in Everyday Clinical Practice

المؤلفون: Rüland, Anna Marlene, Hagemann, Friederike, Reinisch, Mattea, Holtschmidt, Johannes, Kümmel, Aylin, Dittmer-Grabowski, Christine, Stöblen, Frank, Rotthaus, Horst, Dreesmann, Volker, Blohmer, Jens-Uwe, Kümmel, Sherko

المصدر: Breast Care ; volume 13, issue 2, page 114-118 ; ISSN 1661-3791 1661-3805

الاتاحة: http://dx.doi.org/10.1159/000486388
https://www.karger.com/Article/Pdf/486388

View record in BASE

14

Academic Journal

Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC

المؤلفون: Kümmel, Aylin, Kümmel, Sherko, Blohmer, Jens-Uwe, Faridi, Andree, Nitz, Ulrike, Loibl, Sibylle, von Fritschen, Uwe, Rezek, Daniela, Hagemann, Friederike, Holtschmidt, Johannes, Botzenhardt, Suzan, Reinisch, Mattea

المصدر: Breast Care ; volume 14, issue 3, page 165-169 ; ISSN 1661-3791 1661-3805

الاتاحة: http://dx.doi.org/10.1159/000490040
https://www.karger.com/Article/Pdf/490040

View record in BASE

15

Nachweisverfahren zur Anreicherung und Detektion zirkulierender Tumorzellen aus dem Blut von Patienten mit Glioblastoma multiforme
Detection method for the accumulation and detection of circulating tumor cells from the blood of patients with glioblastoma multiforme

المؤلفون: Holtschmidt, Johannes Claus

الاتاحة: http://data.europeana.eu/aggregation/europeana/2048441/item_4H4D4NJQKUGKLJFXCFC6OCKOQ7AGCMZO

View record in Europeana

16

Academic Journal

First reported use of the Faxitron LOCalizer (TM) Radiofrequency Identification (RFID) system in the axilla- A pilot trial in targeted axillary dissection (TAD)

المؤلفون: Malter, Wolfram, Eichler, Christian, Puppe, Julian, Thangarajah, Fabishy, Mallmann, Peter, Krug, Barbara, Warm, Mathias, Holtschmidt, Johannes

مصطلحات موضوعية: ddc:no

Relation: Malter, Wolfram, Eichler, Christian, Puppe, Julian, Thangarajah, Fabishy, Mallmann, Peter, Krug, Barbara, Warm, Mathias and Holtschmidt, Johannes (2020). First reported use of the Faxitron LOCalizer (TM) Radiofrequency Identification (RFID) system in the axilla- A pilot trial in targeted axillary dissection (TAD). Cancer Res., 80 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

الاتاحة: https://kups.ub.uni-koeln.de/34583/

View record in BASE

17

Academic Journal

First Reported Use of Radiofrequency Identification (RFID) Technique for Targeted Excision of Suspicious Axillary Lymph Nodes in Early Stage Breast Cancer - Evaluation of Feasibility and Review of Current Recommendations

المؤلفون: Malter, Wolfram, Eichler, Christian, Hanstein, Bettina, Mallmann, Peter, Holtschmidt, Johannes

مصطلحات موضوعية: ddc:no

Relation: Malter, Wolfram, Eichler, Christian, Hanstein, Bettina, Mallmann, Peter and Holtschmidt, Johannes (2020). First Reported Use of Radiofrequency Identification (RFID) Technique for Targeted Excision of Suspicious Axillary Lymph Nodes in Early Stage Breast Cancer - Evaluation of Feasibility and Review of Current Recommendations. In Vivo, 34 (3). S. 1207 - 1214. ATHENS: INT INST ANTICANCER RESEARCH. ISSN 1791-7549

الاتاحة: https://kups.ub.uni-koeln.de/33557/

View record in BASE

18

Academic Journal

De-escalated chemotherapy versus endocrine therapy plus pertuzumab plus trastuzumab for HR+/HER2+early breast cancer (BC): First efficacy results from the neoadjuvant WSG-TP-II study.

المؤلفون: Gluz, Oleg, Nitz, Ulrike, Christgen, Matthias, Kuemmel, Sherko, Holtschmidt, Johannes, Priel, Jan, Hartkopf, Andreas, Potenberg, Jochem, Luedtke-Heckenkamp, Kerstin, Just, Marianne, Wuelfing, Pia, Von Schumann, Raquel, Graeser, Monika, Wuerstlein, Rachel, Kates, Ronald E., Kreipe, Hans Heinrich, Harbeck, Nadia

مصطلحات موضوعية: ddc:no

Relation: Gluz, Oleg, Nitz, Ulrike, Christgen, Matthias, Kuemmel, Sherko, Holtschmidt, Johannes, Priel, Jan, Hartkopf, Andreas, Potenberg, Jochem, Luedtke-Heckenkamp, Kerstin, Just, Marianne, Wuelfing, Pia, Von Schumann, Raquel, Graeser, Monika, Wuerstlein, Rachel, Kates, Ronald E., Kreipe, Hans Heinrich and Harbeck, Nadia (2020). De-escalated chemotherapy versus endocrine therapy plus pertuzumab plus trastuzumab for HR+/HER2+early breast cancer (BC): First efficacy results from the neoadjuvant WSG-TP-II study. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

الاتاحة: https://kups.ub.uni-koeln.de/33322/

View record in BASE

19

Periodical

A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients

المصدر: Annals of Surgery; November 2022, Vol. 276 Issue: 5 pe553-e562, 10p

20

Academic Journal

First Reported Use of the Faxitron LOCalizer (TM) Radiofrequency Identification (RFID) System in Europe - Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions

المؤلفون: Malter, Wolfram, Holtschmidt, Johannes, Thangarajah, Fabinshy, Mallmann, Peter, Krug, Barbara, Warm, Mathias, Eichler, Christian

مصطلحات موضوعية: ddc:no

Relation: Malter, Wolfram, Holtschmidt, Johannes, Thangarajah, Fabinshy, Mallmann, Peter, Krug, Barbara, Warm, Mathias and Eichler, Christian (2019). First Reported Use of the Faxitron LOCalizer (TM) Radiofrequency Identification (RFID) System in Europe - Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions. In Vivo, 33 (5). S. 1559 - 1565. ATHENS: INT INST ANTICANCER RESEARCH. ISSN 1791-7549

الاتاحة: https://kups.ub.uni-koeln.de/14314/

View record in BASE

تنقيح النتائج